Dana-Farber Cancer Institute (DFCI): Mapping the Function of Rare Oncogenic Variants

Although some oncogenes and tumor suppressor genes are recurrently mutated at high frequency, the majority of somatic sequence alterations found in cancers occur at low frequency, and the functional consequences of the majority of these mutated alleles remain unknown. We are developing a scalable systematic approach to interrogate the function of cancer-associated gene variants.

Read the abstract

Experimental Approaches

We have developed an approach to generate mutant forms of cDNA clones at high efficiency and are introducing these into cell models to determine their impact on gene expression and tumorigenesis.

Read the detailed Experimental Approaches


Access the Raw/Analyzed Data (DCC)

Access the Dashboard Submission(s)


For questions, please contact Joshua Dempster.

Last updated: September 14, 2018